United Kingdom · Question · Written question
UIN 72034
Tirzepatide
Original
Introduced
29 August 2025
Last action
9 September 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
9 September 2025
Summary
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the NHS eligibility criteria for tirzepatide on levels of access to treatment for people (a) with obesity and (b) who do not meet
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 August 2025
Written question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the NHS eligibility criteria for tirzepatide on levels of access to treatment for people (a) with obesity and (b) who do not meet
Source: Commons
9 September 2025
Answer
The eligibility criteria for tirzepatide, under brand name Mounjaro, for the management of weight have been set independently by the National Institute for Health and Care Excellence (NICE) following a full appraisal of the clinical and cost effectiveness...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-08-29/72034
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1828791
- uk · wq-1828791 · source updated 9 September 2025